These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9531665)

  • 21. [Drug therapy of arthroses].
    Felder M; Wagenhäuser FJ
    Orthopade; 1986 Sep; 15(5):379-87. PubMed ID: 3531978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Animal experiment studies on the effect of intra-articular injections of antiphlogistic-antirheumatic agents on articular cartilage in vivo].
    Kalbhen DA; Schauer M; Wentsche B
    Z Rheumatol; 1978; 37(11-12):380-94. PubMed ID: 153678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of the chondroprotective agent Cosequin DS on bovine articular cartilage exposed in vitro to nonsteroidal antiinflammatory agents.
    Lippiello L; Han MS; Henderson T
    Vet Ther; 2002; 3(2):128-35. PubMed ID: 19750743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intra-articular injection of hyaluronic acid as an alternative option to corticosteroid injections for arthrosis].
    Kuiper-Geertsma DG; Bijlsma JW
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2188-92. PubMed ID: 11103254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of osteoarthritis with tiaprofenic acid: biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model.
    Howell DS; Pita JC; Muller FJ; Manicourt DH; Altman RD
    J Rheumatol Suppl; 1991 Feb; 27():138-42. PubMed ID: 2027115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the evidence? There is only very weak clinical trial evidence to support the use of glucosamine and chondroitin supplements for osteoarthritis in dogs.
    McKenzie BA
    J Am Vet Med Assoc; 2010 Dec; 237(12):1382-3. PubMed ID: 21155677
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biochemical studies of potentially antiarthritic drugs].
    Greiling H
    Z Rheumatol; 1983; 42(4):153-8. PubMed ID: 6228079
    [No Abstract]   [Full Text] [Related]  

  • 28. Conservative management of spinal osteoarthritis with glucosamine sulfate and chiropractic treatment.
    Gottlieb MS
    J Manipulative Physiol Ther; 1997; 20(6):400-14. PubMed ID: 9272473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Villonodular synovitis in the dog: a report of four cases.
    Akerblom S; Sjöström L
    Vet Comp Orthop Traumatol; 2006; 19(2):87-92. PubMed ID: 16810350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease.
    Kelly GS
    Altern Med Rev; 1998 Feb; 3(1):27-39. PubMed ID: 9600024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinico-toxicologic aspects of non-steroidal anti-inflammatory agents in the dog and cat].
    Vollmar AM
    Tierarztl Prax; 1993 Apr; 21(2):149-52. PubMed ID: 8488502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days.
    McNamara PS; Barr SC; Erb HN
    Am J Vet Res; 1996 Sep; 57(9):1390-4. PubMed ID: 8874739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of NSAIDS on murine antigen induced arthritis. I. Investigation of antiinflammatory and chondroprotective effects.
    de Vries BJ; van den Berg WB
    J Rheumatol Suppl; 1989 Aug; 18():10-8. PubMed ID: 2810292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cartilage metabolism and anti-inflammatory drugs in osteoarthritis.
    Hess EV; Herman JH
    Am J Med; 1986 Nov; 81(5B):36-43. PubMed ID: 3538869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
    Sanguinetti CM; Bonifazi F
    Minerva Med; 1976 Oct; 67(52):3391-5. PubMed ID: 792738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel drug treatment strategies for osteoarthritis.
    Creamer P; Dieppe PA
    J Rheumatol; 1993 Sep; 20(9):1461-4. PubMed ID: 8164198
    [No Abstract]   [Full Text] [Related]  

  • 37. Knee osteoarthritis management therapies.
    Leslie M
    Pain Manag Nurs; 2000 Jun; 1(2):51-7. PubMed ID: 11706459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degenerative joint disease: multiple joint involvement in young and mature dogs.
    Olsewski JM; Lust G; Rendano VT; Summers BA
    Am J Vet Res; 1983 Jul; 44(7):1300-8. PubMed ID: 6881668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of nonsteroidal anti-inflammatory drugs, oral preparations, and viscosupplementation in conservative treatment of cartilage lesions].
    Müezzinoğlu S; Buluç L
    Acta Orthop Traumatol Turc; 2007; 41 Suppl 2():48-53. PubMed ID: 18180584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility) in a cartilage explant model of articular inflammation.
    Pearson W; Orth MW; Lindinger MI
    J Vet Pharmacol Ther; 2007 Dec; 30(6):523-33. PubMed ID: 17991220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.